½ÃÀ庸°í¼­
»óǰÄÚµå
1541763

¼¼°èÀÇ »êºÎÀΰú ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç°, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°(2024-2032³â)

Gynecology Devices Market Report by Product (Surgical Devices, Hand Instruments, and Others), End Use (Hospitals and Clinics, Diagnostic Centers, and Others), and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 141 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è »êºÎÀΰú ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 128¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¾ÕÀ¸·Î IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 231¾ï ´Þ·¯¿¡ À̸£¸ç, 2024-2032³â »çÀÌ¿¡ 6.6%ÀÇ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

»êºÎÀΰú¿ë ±â±â´Â ¿©¼º »ý½Ä±â ½Ã½ºÅÛ°ú °ü·ÃµÈ Áúº´À» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌµé ±â±â´Â ÄÝÆ÷½ºÄ«ÇÇ, ³­°ü °áÂû¼ú, Àڱ󻸷 »ý°Ë, ³­¼Ò³¶Á¾ ÀýÁ¦¼ú, Àü±âÀýÁ¦¼ú(LEEP), Àڱó»ÇÇÀÓ±â±â(IUD) »ðÀÔ¼ú, È®´ë¡¤¼ÒÆÄ¼ú(D&C) ½Ç½Ã¸¦ Áö¿øÇÕ´Ï´Ù. ³Î¸® »ç¿ëµÇ´Â »êºÎÀΰú ±â±â¿¡´Â Á¦¿Õ Àý°³ ºÐ¸¸¿ë Áý°Ô¿Í Ŭ·¥ÇÁ, Àڱà °æºÎÀÇ ±ÙÀ°À» ´Ã¸®´Â Àڱà °æºÎ È®Àå±â, Àڱà °æºÎÀÇ Àü ¾Ç¼º º´º¯¿ë ÆÝÄ¡ Áý°Ô µîÀÌ ÀÖ½À´Ï´Ù. ÃÖ±Ù ·¹ÀÌÀúÀÇ Áøº¸·Î ³¶Á¾, Àڱ󻸷Áõ, »ý½Ä±â »ç¸¶±Í, ÀڱñÙÁ¾, ÀÚ±ÃÀÌ»ó ÃâÇ÷, ÀÚ±Ã¿Ü ÀÓ½Å, ¿ä½Ç±ÝÀ» Ä¡·áÇϱâ À§ÇÑ »êºÎÀΰú ±â±â ¼ö¿ä°¡ ¼¼°èÀûÀ¸·Î ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

»êºÎÀΰú ±â±â ½ÃÀå µ¿Çâ

Àڱà °æºÎ¾Ï, Áú Èæ»öÁ¾, ºÎÁ¤ ÃâÇ÷, ¿ù°æ ºÒ¼ø, ´Ù³¶¼º ³­¼Ò ÁõÈıº°ú °°Àº »êºÎÀΰú ÁúȯÀ» ¾Î°íÀÖ´Â ¿©¼ºÀÇ ¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, Á¤±â °ËÁøÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. Àúħ½À(MI) ÀýÂ÷ÀÇ »õ·Î¿î µ¿Çâ°ú 3Â÷¿ø(3D) ³»½Ã°æ°ú °°Àº ¿µ»ó ±â±âÀÇ ÀÌ¿ë Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀϺΠÁ¦Á¶¾÷ü´Â Á¤È®ÇÏ°í ½Å¼ÓÇÑ Áø´ÜÀ» Á¦°øÇÏ°í ¼ö¼ú ½Ã°£À» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀÎ ±â±â¸¦ °³¹ßÇϱâ À§ÇØ R&D Ȱµ¿¿¡ ÅõÀÚ Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ³»±¸¼ºÀÌ ³ô°í ¿ÀÅäŬ·¹ÀÌºê ¸ê±ÕÀÌ ¿ëÀÌÇÑ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¢±¹ÀÇ º¸°Ç´ç±¹Àº »êºÎÀΰú º´¿øÀÇ ¼ö¸¦ ´Ã¸®°í ±âÁ¸ º´¿øÀÇ ¼­ºñ½º¸¦ °³¼±ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. À̰ÍÀº ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ »êºÎÀΰú ±â±â ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇØ, ÇâÈÄ ¾î¶»°Ô ÃßÀÌÇØ °¥ °ÍÀΰ¡?
  • COVID-19´Â ¼¼°è »êºÎÀΰú ±â±â ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • Á¦Ç°º° ½ÃÀå ºÐ¼®Àº?
  • ÃÖÁ¾ ¿ëµµº° ½ÃÀå ºÐ¼®Àº?
  • ¾÷°èÀÇ ¹ë·ùüÀÎÀÇ ´Ù¾çÇÑ ´Ü°è¶õ?
  • ¾÷°èÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú µµÀüÀº ¹«¾ùÀΰ¡?
  • ¼¼°è »êºÎÀΰú ±â±â ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ÁøÃâ±â¾÷Àº?
  • ¾÷°è °æÀïµµ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°è »êºÎÀΰú ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • ¿Ü°ú¿ë ±â±â
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : À¯Çüº°
      • »êºÎÀΰú ³»½Ã°æ ÀåÄ¡
        • ½ÃÀå µ¿Çâ
        • ÁÖ¿ä À¯Çü
        • Àڱðæ
        • Áú°æ
        • ÀýÁ¦°æ
        • º¹°­°æ
        • ³»½Ã°æ ¿µ»ó ½Ã½ºÅÛ
        • ½ÃÀå ¿¹Ãø
      • Àڱà ³»¸· ÀýÁ¦ ÀåÄ¡
        • ½ÃÀå µ¿Çâ
        • ÁÖ¿ä À¯Çü
        • ¿­¼ö ÀýÁ¦ ÀåÄ¡
        • °íÁÖÆÄ ÀýÁ¦ ÀåÄ¡
        • dz¼± ÀýÁ¦ ÀåÄ¡
        • ±âŸ
        • ½ÃÀå ¿¹Ãø
      • À¯Ã¼ °ü¸® ½Ã½ºÅÛ
      • ¿©¼º ºÒÀÓ ¼ö¼ú¡¤ÇÇÀÓ ±â±â
        • ½ÃÀå µ¿Çâ
        • ÁÖ¿ä À¯Çü
        • ¿µ±¸ ÇÇÀÓ
        • Àڱó» ÇÇÀÓ ±â±â(IUD)
        • Áú³» ¸µ
        • ÇÇÇÏ ÇÇÀÓ ÀÓÇöõÆ®
        • ½ÃÀå ¿¹Ãø
    • ½ÃÀå ¿¹Ãø
  • ¼ö¿ë±â±â
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä À¯Çü
      • Áú°æ
      • Å׳ªÅ§·³
      • Å¥·¿
      • Åõ°üħ
      • »ý°Ë Áý°Ô
      • ±âŸ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ

Á¦7Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ ¿ëµµº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • Áø´Ü¼¾ÅÍ
  • ±âŸ

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦9Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Boston Scientific Corporation
    • CooperSurgical Inc.
    • Fresenius Medical Care AG & Co. KGAA
    • General Electric Company
    • Hologic Inc.
    • Johnson & Johnson
    • Karl Storz SE & Co. KG
    • Medtronic plc
    • Olympus Corporation
    • Richard Wolf GmbH
    • Siemens AG
    • Stryker Corporation
JHS 24.09.20

The global gynecology devices market size reached US$ 12.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.

Gynecology devices are used to treat conditions associated with the female reproductive system. These devices assist in performing colposcopy, loop tubal ligation, endometrial biopsy, ovarian cystectomy, electrical excision procedure (LEEP), intrauterine device (IUD) insertion, and dilation and curettage (D&C). Some of the widely used gynecology devices are forceps and clamps for caesarian delivery, cervical dilators for stretching the cervical muscles, and punch forceps for premalignant lesions of the cervix. Recent advances in lasers have escalated the demand for gynecology devices across the globe to treat cysts, endometriosis, genital warts, fibroid tumors, abnormal uterine bleeding, ectopic pregnancy, and urinary incontinence.

Gynecology Devices Market Trends:

A significant rise in the number of women with gynecological conditions, such as cervical cancer, vaginal melanoma, extended bleeding, irregular menstrual cycles, and polycystic ovary syndrome, represents one of the primary factors fueling the market growth. Moreover, growing awareness about the benefits of regular check-ups is influencing the market positively. The emerging trend of minimally invasive (MI) procedures and increasing utilization of imaging devices like three-dimensional (3D) endoscopes is also contributing to the market growth. Apart from this, several manufacturers are investing in research and development (R&D) activities to develop efficient devices that can provide accurate and quick diagnoses and minimize operating time. This, in confluence with the rising need for durable and easy autoclavable surgical instruments, is bolstering the market growth. Furthermore, health authorities of numerous countries are focusing on increasing the number of hospitals for gynecology and improving the services in existing ones. This is anticipated to drive the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gynecology devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product and end use.

Breakup by Product:

Surgical Devices

Gynecological Endoscopy Devices

Hysteroscope

Colposcope

Resectoscope

Laparoscope

Endoscopic Imaging Systems

Endometrial Ablation Devices

Hydrothermal Ablation Devices

Radiofrequency Ablation Devices

Balloon Ablation Devices

Others

Fluid Management Systems

Female Sterilization/Contraceptive Devices

Permanent Birth Control

Intra Uterine Devices (IUD)

Intravaginal Rings

Subdermal Contraceptive Implants

Hand Instruments

Vaginal Speculum

Tenaculum

Curettes

Trocars

Biopsy Forceps

Others

Others

Breakup by End Use:

Hospitals and Clinics

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CooperSurgical Inc., Fresenius Medical Care AG & Co. KGAA, General Electric Company, Hologic Inc., Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens AG and Stryker Corporation.

Key Questions Answered in This Report:

  • How has the global gynecology devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global gynecology devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global gynecology devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gynecology Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Surgical Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Gynecological Endoscopy Devices
        • 6.1.2.1.1 Market Trends
        • 6.1.2.1.2 Major Types
        • 6.1.2.1.2.1 Hysteroscope
        • 6.1.2.1.2.2 Colposcope
        • 6.1.2.1.2.3 Resectoscope
        • 6.1.2.1.2.4 Laparoscope
        • 6.1.2.1.2.5 Endoscopic Imaging Systems
        • 6.1.2.1.3 Market Forecast
      • 6.1.2.2 Endometrial Ablation Devices
        • 6.1.2.2.1 Market Trends
        • 6.1.2.2.2 Major Types
        • 6.1.2.2.2.1 Hydrothermal Ablation Devices
        • 6.1.2.2.2.2 Radiofrequency Ablation Devices
        • 6.1.2.2.2.3 Balloon Ablation Devices
        • 6.1.2.2.2.4 Others
        • 6.1.2.2.3 Market Forecast
      • 6.1.2.3 Fluid Management Systems
        • 6.1.2.3.1 Market Trends
        • 6.1.2.3.2 Market Forecast
      • 6.1.2.4 Female Sterilization/Contraceptive Devices
        • 6.1.2.4.1 Market Trends
        • 6.1.2.4.2 Major Types
        • 6.1.2.4.2.1 Permanent Birth Control
        • 6.1.2.4.2.2 Intra Uterine Devices (IUD)
        • 6.1.2.4.2.3 Intravaginal Rings
        • 6.1.2.4.2.4 Subdermal Contraceptive Implants
        • 6.1.2.4.3 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Hand Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Vaginal Speculum
      • 6.2.2.2 Tenaculum
      • 6.2.2.3 Curettes
      • 6.2.2.4 Trocars
      • 6.2.2.5 Biopsy Forceps
      • 6.2.2.6 Others
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Boston Scientific Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 CooperSurgical Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Fresenius Medical Care AG & Co. KGAA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 General Electric Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Hologic Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Johnson & Johnson
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Karl Storz SE & Co. KG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 SWOT Analysis
    • 13.3.8 Medtronic plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Olympus Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Richard Wolf GmbH
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11 Siemens AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.13 Stryker Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦